ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2012

Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience.

L R Molife et al.PubMed ↗Publisher ↗

No numbers read from the abstract.